Advances and considerations in AD tau-targeted immunotherapy

The multifactorial and complex nature of Alzheimer's disease (AD) has made it difficult to identify therapeutic targets that are causally involved in the disease process. However, accumulating evidence from experimental and clinical studies that investigate the early disease process point towar...

Full description

Bibliographic Details
Main Authors: Alice Bittar, Nemil Bhatt, Rakez Kayed
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996119303821